Financial Engines Advisors’s bioAffinity Technologies BIAF Stock Holding History

Financial Engines Advisors’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,158	Closed	-$104K	–	287
2022 Q4	$104K	Buy	+2,158	New	+$164K	﹤0.01%	286

Other funds holding BIAF

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Engines Advisors's BIAF Position: Q1 2023 in Review

Financial Engines Advisors sold out of bioAffinity Technologies (BIAF) in Q1 2023, closing a stake of 2,158 shares — an estimated $104K sold.

Financial Engines Advisors first reported a position in BIAF in Q4 2022 and held it in 1 quarter. The position peaked at $104K in Q4 2022. 6 funds tracked by Wall St. Rank hold BIAF as of Q1 2023.

Financial Engines Advisors reported no remaining bioAffinity Technologies position as of Q1 2023 after selling out during the quarter.
Financial Engines Advisors sold 2,158 bioAffinity Technologies shares in Q1 2023, an estimated $104K.
Financial Engines Advisors first reported a position in bioAffinity Technologies in Q4 2022 and held it in 1 quarter.
Financial Engines Advisors's bioAffinity Technologies position peaked at $104K in Q4 2022.
6 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2023.

Based on Financial Engines Advisors's 13F filing for Q1 2023, filed 12 May 2023.